Cargando…
A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model
Mucin1 (MUC1) is a highly glycosylated transmembrane protein that plays a crucial role in the lubrication and protection of normal epithelial cells. However, MUC1 has emerged as a potential target for cancer therapy because it is overexpressed and functions in several types of cancers. Recently, we...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073888/ https://www.ncbi.nlm.nih.gov/pubmed/29987260 http://dx.doi.org/10.3390/ijms19072004 |
_version_ | 1783344291960061952 |
---|---|
author | Wu, Guang Maharjan, Sony Kim, Dongbum Kim, Jung Nam Park, Byoung Kwon Koh, Heeju Moon, Kyungduk Lee, Younghee Kwon, Hyung-Joo |
author_facet | Wu, Guang Maharjan, Sony Kim, Dongbum Kim, Jung Nam Park, Byoung Kwon Koh, Heeju Moon, Kyungduk Lee, Younghee Kwon, Hyung-Joo |
author_sort | Wu, Guang |
collection | PubMed |
description | Mucin1 (MUC1) is a highly glycosylated transmembrane protein that plays a crucial role in the lubrication and protection of normal epithelial cells. However, MUC1 has emerged as a potential target for cancer therapy because it is overexpressed and functions in several types of cancers. Recently, we produced a monoclonal antibody (the anti-hMUC1 antibody) specific to the extracellular region of the MUC1 subunit MUC1-C to evaluate the utility of using anti-MUC1 antibodies in pancreatic cancer models. The anti-hMUC1 antibody recognized the MUC1-C protein in pancreatic cancer cells. Based on immunostaining and confocal image analyses, the anti-hMUC1 antibody initially bound to the cell membrane then was internalized in cancer cells that express MUC1. The anti-hMUC1 antibody suppressed epidermal growth factor (EGF)-mediated extracellular signal–regulated kinase (ERK) phosphorylation and cyclin D1 expression. When the anti-hMUC1 antibody was injected into a xenograft mouse model and traced using an in vivo imaging system, we observed that the anti-hMUC1 antibody was localized to MUC1-expressing pancreatic tumors. Importantly, the anti-hMUC1 monoclonal antibody suppressed pancreatic tumor growth in mice. According to immunohistochemistry analysis using a pancreatic cancer tissue array and the anti-hMUC1 antibody, MUC1 was highly expressed in human pancreatic cancer tissues compared to normal tissues. Therefore, we conclude that the anti-hMUC1 antibody specifically targets MUC1 and suppresses its function in pancreatic cancer in vitro and in vivo and can be further developed as a promising targeted therapy to treat pancreatic cancer. |
format | Online Article Text |
id | pubmed-6073888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60738882018-08-13 A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model Wu, Guang Maharjan, Sony Kim, Dongbum Kim, Jung Nam Park, Byoung Kwon Koh, Heeju Moon, Kyungduk Lee, Younghee Kwon, Hyung-Joo Int J Mol Sci Article Mucin1 (MUC1) is a highly glycosylated transmembrane protein that plays a crucial role in the lubrication and protection of normal epithelial cells. However, MUC1 has emerged as a potential target for cancer therapy because it is overexpressed and functions in several types of cancers. Recently, we produced a monoclonal antibody (the anti-hMUC1 antibody) specific to the extracellular region of the MUC1 subunit MUC1-C to evaluate the utility of using anti-MUC1 antibodies in pancreatic cancer models. The anti-hMUC1 antibody recognized the MUC1-C protein in pancreatic cancer cells. Based on immunostaining and confocal image analyses, the anti-hMUC1 antibody initially bound to the cell membrane then was internalized in cancer cells that express MUC1. The anti-hMUC1 antibody suppressed epidermal growth factor (EGF)-mediated extracellular signal–regulated kinase (ERK) phosphorylation and cyclin D1 expression. When the anti-hMUC1 antibody was injected into a xenograft mouse model and traced using an in vivo imaging system, we observed that the anti-hMUC1 antibody was localized to MUC1-expressing pancreatic tumors. Importantly, the anti-hMUC1 monoclonal antibody suppressed pancreatic tumor growth in mice. According to immunohistochemistry analysis using a pancreatic cancer tissue array and the anti-hMUC1 antibody, MUC1 was highly expressed in human pancreatic cancer tissues compared to normal tissues. Therefore, we conclude that the anti-hMUC1 antibody specifically targets MUC1 and suppresses its function in pancreatic cancer in vitro and in vivo and can be further developed as a promising targeted therapy to treat pancreatic cancer. MDPI 2018-07-09 /pmc/articles/PMC6073888/ /pubmed/29987260 http://dx.doi.org/10.3390/ijms19072004 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Guang Maharjan, Sony Kim, Dongbum Kim, Jung Nam Park, Byoung Kwon Koh, Heeju Moon, Kyungduk Lee, Younghee Kwon, Hyung-Joo A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title_full | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title_fullStr | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title_full_unstemmed | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title_short | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model |
title_sort | novel monoclonal antibody targets mucin1 and attenuates growth in pancreatic cancer model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073888/ https://www.ncbi.nlm.nih.gov/pubmed/29987260 http://dx.doi.org/10.3390/ijms19072004 |
work_keys_str_mv | AT wuguang anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT maharjansony anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kimdongbum anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kimjungnam anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT parkbyoungkwon anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kohheeju anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT moonkyungduk anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT leeyounghee anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kwonhyungjoo anovelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT wuguang novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT maharjansony novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kimdongbum novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kimjungnam novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT parkbyoungkwon novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kohheeju novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT moonkyungduk novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT leeyounghee novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel AT kwonhyungjoo novelmonoclonalantibodytargetsmucin1andattenuatesgrowthinpancreaticcancermodel |